CRP and COVID-19: COVID-19 patients with higher inflammatory status, indicated by C-reactive Protein (CRP), showed significantly elevated TAA during acute and mid phases (P = 0.03 for both), while no differences were observed in the late phase (P = 0.37; Figure 2B).